// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

GENE-31. IDENTIFICATION OF CORE AND CONTEXT-SPECIFIC FITNESS GENES IN GLIOBLASTOMA STEM CELLS VIA GENOME-WIDE CRISPR-Cas9 SCREENS

Graham MacLeod - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Glioblastoma

N/A

THE THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST REGISTRY: THE “COOL” REGISTRY

Michael C.Y. Chan - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE

Shirin Karimi - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Medulloblastoma

N/A

CLINICAL OUTCOMES OF LEFT MAIN CROSSOVER STENTING FOR OSTIAL LEFT ANTERIOR DESCENDING ARTERY LESIONS VERSUS OSTIAL STENTING ALONE

Osama Essam ElKhateeb - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM

Fabien Forest - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral metastases

N/A

A RARE CASE OF RECURRENT ACUTE CORONARY SYNDROME CAUSED BY A PRIMARY AORTIC VALVE UNDIFFERENTIATED SARCOMA

Martine Parent - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

GENE-34. THERAPEUTICALLY TARGETING EPIGENOMIC AND TRANSCRIPTIONAL DYSFUNCTION IN ATRX-DEFICIENT GLIOMA

Carla Danussi - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Gliomas

N/A

PDTM-22. A C19MC-LIN28A-MYCN ONCOGENIC CIRCUIT DRIVEN BY HIJACKED SUPER-ENHANCERS IS A DISTINCT THERAPEUTIC VULNERABILITY IN ETMRS – A LETHAL BRAIN TUMOR

Iqra Mumal - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Brain cancer

N/A

LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

Fabio Iwamoto - Society for Neuro-Oncology (SNO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Anaplastic astrocytoma

Temozolomide

CARDIOTOXICITY PHENOTYPES IN WOMEN TREATED WITH ANTHRACYCLINES AND TRASTUZUMAB FOR EARLY STAGE BREAST CANCER

Mark T. Nolan - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Breast cancer

Trastuzumab

USE OF ECHOCARDIOGRAPHIC PARAMETERS TO PREDICT CLINICAL BENEFIT FROM THE MITRACLIP PROCEDURE: A SYSTEMATIC REVIEW AND METAREGRESSION

Nawid Sayed - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

BET PROTEIN INHIBITION AND COGNITION: A PRE-SPECIFIED SUBSTUDY OF THE BETONMACE PHASE 3 TRIAL EVALUATING APABETALONE IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROME

Kausik K. Ray - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

RVX-208

FASTER PROGRESSION OF AORTIC STENOSIS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION

Amlie Paquin - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

INEXPENSIVE, HIGH FIDELITY MODEL TO SIMULATE ULTRASOUND-GUIDED PERICARDIOCENTESIS FOR CARDIOLOGY RESIDENT TRAINING

Daniel Belliveau - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

LONG-TERM TREATMENT WITH APIXABAN OF PARTICIPANTS FOLLOWING CONCLUSION OF AVERROES

Alexander Benz - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

apixaban

CENTRAL HYPERTENSION IN PATIENTS WITH THORACIC AORTIC ANEURYSMS WITHOUT ESTABLISHED DIAGNOSIS OF HYPERTENSION: PREVALENCE AND ASSOCIATION WITH ANEURYSM SIZE

Jasjit Rooprai - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

PATIENTS WITH ACUTE CORONARY SYNDROME, ELEVATED ATHEROGENIC LIPOPROTEINS, AND PRIOR CORONARY ARTERY BYPASS GRAFTING DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: INSIGHTS FROM THE ODYSSEY OUTCOMES TRIAL

Shaun G. Goodman - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Alirocumab

FOLLOW THE BUBBLES

Mehdi Afshar - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sinus of valsalva aneurysm

N/A

A BREATH TOWARDS A HEALTHIER HEART: USING RESPIRATORY PHYSIOLOGY TO UNDERSTAND AND PREVENT CARDIOVASCULAR DISEASE

Suurya Krishnan - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

APABETALONE, AN EPIGENETIC BET INHIBITOR IN A PHASE 3 TRIAL, INHIBITS VASCULAR INFLAMMATION AND CELLULAR ADHESION LEADING TO BENEFICIAL OUTCOMES IN CVD PATIENTS

Laura Tsujikawa - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

RVX-208

Copyright © 2026. QuantiNova All rights reserved